GlassScriptPhysician profile
Kaylee A Williams
NPI 1073751723
$2,148.55
in general payments reported to CMS, 2019-2025
28 companies · $381 in 2025
The $381 reported for 2025 was more than what 75% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $900 · 2022: $531 · 2023: $169 · 2024: $167 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $287.73 | 2021-2022 | |
| Organon LLC | $263.38 | 2021-2025 | Nexplanon, Nuvaring |
| Therapeuticsmd, INC. | $209.10 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $208.56 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $144.21 | 2021-2025 | Gardasil 9, Gardasil |
| Abbvie INC. | $108.51 | 2021-2022 | |
| Daiichi Sankyo INC. | $88.43 | 2021-2022 | |
| Exact Sciences Corporation | $85.49 | 2024-2025 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $83.55 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $71.95 | 2021-2022 | |
| Millicent US INC | $66.25 | 2025 | Intrarosa, Femlyv |
| Pfizer INC. | $63.49 | 2023-2025 | |
| Coopersurgical, INC. | $54.53 | 2021 | |
| Avion Pharmaceuticals | $54.43 | 2021-2023 | Balcoltra |
| Astellas Pharma US INC | $50.72 | 2024-2025 | Veozah |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $46.25 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $39.55 | 2025 | Qelbree |
| Lupin INC. | $33.40 | 2021 | |
| Ebi, LLC | $26.89 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Acacia Pharma INC | $22.67 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.08 | 2022 | |
| Mission Pharmacal Company | $20.08 | 2021 | |
| Minerva Surgical, INC | $19.89 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.77 | 2022 | |
| Mylan Pharmaceuticals INC. | $15.58 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.29 | 2021 | |
| Amag Pharmaceuticals, INC. | $15.08 | 2021 | |
| Channel Medsystems, INC. | $12.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaylee Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.